OnsiteGene introduces myNAT™, a sealed-cartridge PCR system delivering flexible, sample-to-answer molecular diagnostics with precision. LOS ALTOS, CA, UNITED STATES, September 11, 2025 / EINPresswire.com / -- OnsiteGene Inc. has published a comprehensive review of its myNAT™ Sample-to-Answer Open-Panel PCR Instrument , showcasing the system’s innovative design, functionality, certifications, and potential applications across clinical, public health, environmental, and agricultural domains. Intro

Proposed $50 million 5-year partnerships with HPE would enlarge the U's computing power using NVIDIA chips, driving new discoveries and innovation in cancer, Alzheimer's and mental health research SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- The University of Utah is looking to join forces with two powerhouse tech firms to accelerate research and discovery using artificial intelligence (AI). The agreement with Hewlett Packard Enterprise (HPE) and AI chipmaker NVIDIA and will amplify the univer

Drugs and the technologies used to deliver them evolve rapidly, and methods to evaluate them must be continually adapted to ensure the safety and efficacy of new medicines. An excellent illustration of this process of adaptation is recent work by Center for Drug Evaluation and Research (CDER) statisticians who developed innovative and more efficient ways to evaluate a class of products that deliver drugs via the skin. The improved statistical analysis methods greatly enhance the power of drug de

AbbVie said it has fended off US generic competition for one of its top-selling drugs until 2037. The company announced in a securities filing on Thursday that it has settled legal battles with all of the manufacturers that sought FDA approval to market generic versions of Rinvoq, also known as upadacitinib. While the announcement was light on details, AbbVie said “no generic entry for any upadacitinib tablets is expected prior to April 2037,” assuming Rinvoq is granted pediatric exclusivity. Pe

Bengaluru: Merck's pneumococcal vaccine triggered immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker said on Thursday. The company was testing the shot, Capvaxive , against its older vaccine Pneumovax 23 , in children aged two years and above and teens aged below 18 years, who have completed a primary pediatric pneumococcal vaccination regimen, and have one or more chronic medical conditions that put them at increased risk. Capva

Zentiva traces its roots back hundreds of years to a small pharmacy that still operates in the Czech Republic’s capital. Following CapVest Partners' takeover of Germany’s Stada earlier this month, another private equity group is looking to cash in on Europe’s generic medicines manufacturing scene.Chicago-based investment firm GTCR has inked a deal to acquire Advent International's Prague-based generics manufacturer Zentiva, according to a Sept. 11 press release from Advent. The purchase

A federal appeals court on Thursday rejected Novartis’ challenge against Medicare drug price negotiations, a week after tossing similar cases brought by Johnson & Johnson and Bristol Myers Squibb. The US Court of Appeals for the Third Circuit wrote in its opinion that participation in drug price negotiations is voluntary, and thus doesn’t violate Novartis’ free speech or property rights. As part of its reasoning, the court cited its decisions in the J&J and Bristol Myers cases . The Inflation Re

PHILADELPHIA, Sept. 11, 2025 /PRNewswire/ -- NastLaw LLC and Direct Purchaser Plaintiffs Announce: If you purchased certain named generic pharmaceutical drugs directly from certain pharmaceutical manufacturers from May 1, 2009 through December 31, 2019 , your rights may be affected by proposed class action settlements. A federal court authorized this notice. This is not a solicitation from a lawyer. What is the lawsuit about? Two proposed settlements have been reached in a class action lawsuit

PRAGUE, LONDON and CHICAGO, Sept. 11, 2025 /PRNewswire/ -- Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR. Since acquiring Zentiva from Sanofi in 2018, Advent has worked closely with the management team to successfully transform the business, whilst investing to expand Zentiva's portfolio of medicines and manufacturing footprint, both organically and through targeted

SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it has performed an in silico analysis of the primers sets used in its Co-Primers®-based PCR tests for the detection of chikungunya virus (or "CHIKV"), showing a high homology against over 1,200 CHIKV sequences and confirming reactivity of the CHIKV p